Showing results (81-90 of 99) with videos related to
Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2026
TBCRC 048 (Olaparib Expanded) Expansion Cohorts: Phase II Study of Olaparib Monotherapy for Patients With Metastatic Breast Cancer With Germline Mutations in PALB2 or Somatic Mutations in BRCA1 or BRCA2Nadine M Tung, Mark E Robson, Tianyu Li, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2022
Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian CancersFelipe Batalini, Doga C Gulhan, Victor Mao, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 4, 2020
Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology GuidelineNadine M Tung, Judy C Boughey, Lori J Pierce, et al.Cancer|December 26, 2022
The risks of cancer in older women with BRCA pathogenic variants: How far have we come?Kelly A Metcalfe, Jacek Gronwald, Nadine M Tung, et al.NPJ Breast Cancer|May 10, 2022
A prospective trial of treatment de-escalation following neoadjuvant paclitaxel/trastuzumab/pertuzumab in HER2-positive breast cancerAdrienne G Waks, Neelam V Desai, Tianyu Li, et al.JAMA Oncology|April 27, 2023
Assessment of the HER2DX Assay in Patients With ERBB2-Positive Breast Cancer Treated With Neoadjuvant Paclitaxel, Trastuzumab, and PertuzumabAdrienne G Waks, Esther R Ogayo, Laia Paré, et al.Journal of the National Cancer Institute|October 11, 2025
Prognostic value of visually and computationally assessed tumor-infiltrating lymphocytes in early-stage triple-negative breast cancer (TBCRC-030)Guilherme Nader-Marta, Xiangying Chu, Satabhisa Mukhopadhyay, et al.Journal of the American College of Surgeons|May 17, 2023
Impact of Neoadjuvant Paclitaxel/Trastuzumab/Pertuzumab on Breast Tumor Downsizing for Patients with HER2+ Breast Cancer: Single-Arm Prospective Clinical TrialAnna Weiss, Tianyu Li, Neelam V Desai, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2010
Efficacy of neoadjuvant Cisplatin in triple-negative breast cancerDaniel P Silver, Andrea L Richardson, Aron C Eklund, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2021
Updated Standardized Definitions for Efficacy End Points (STEEP) in Adjuvant Breast Cancer Clinical Trials: STEEP Version 2.0Sara M Tolaney, Elizabeth Garrett-Mayer, Julia White, et al.Pageof 10